Delivery Order SPE2DR25D1017-SPE2DR26F9AME
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on November 25, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 count, with a ceiling value of $2,338.65. The contract represents a firm fixed-price delivery order with an ultimate completion date of November 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,687.77 by the Defense Logistics Agency (DLA) on September 15, 2025, with an ultimate completion date of September 16, 2025. The contract is for the supply of Ambien CR 6.25 mg tablets in quantities of 100, to be delivered to the contractor's location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement on a non-set-aside basis. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $2,564.77 delivery order by the Defense Logistics Agency on September 8, 2025, for the supply of Ambien CR 6.25 mg tablets (100 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,234.63 on December 1, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units. This firm fixed-price delivery order is scheduled for completion by December 2, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award utilized competitive procedures with no set-aside designation, reflecting AmerisourceBergen's capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a contract ceiling value of $1,660.44. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively made. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 9, 2025....
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,132.55 by the Defense Logistics Agency's Medical Supply Chain on September 23, 2025, for the delivery of Ambien CR 6.25 mg tablets in quantities of 100 units. The order, with a firm fixed price structure and an ultimate completion date of September 24, 2025, represents a non-competitive award under an existing contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,613.64 for 100 tablets of Ambien CR 6.25 mg on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Ambien CR 6.25 mg tablets (100 count) with a ceiling value of $1,345.73. This competitively awarded, non-set-aside contract employs firm fixed pricing and is scheduled for completion by December 10, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a ceiling value of $3,686.56. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The ultimate completion date is set for September 8, 2025, and performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,894.81 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on November 3, 2025, with completion scheduled for November 4, 2025. This competitively awarded, non-set-aside contract utilized firm fixed pricing and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The award represents a child contract under AmerisourceBergen's broader...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9AMEDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on November 28, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a contract value of $2,567.91 and a completion date of December 1, 2025. This non-competitive delivery order was issued under a firm fixed-price arrangement and represents a continuation of the company's ongoing pharmaceutical supply relationship with the federal government. The performance location is the company's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems and other federal medical procurement needs. AmerisourceBergen Drug Corp's continued awards across the DLA's medical supply chain demonstrate its established capability as a critical vendor for federal pharmaceutical distribution, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 11/27/25 |